Adaptive Biotechnologies Corp Quarterly Depreciation in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Adaptive Biotechnologies Corp quarterly/annual Depreciation history and growth rate from Q1 2019 to Q1 2024.
  • Adaptive Biotechnologies Corp Depreciation for the quarter ending March 31, 2024 was $4.79M, a 4.26% decline year-over-year.
  • Adaptive Biotechnologies Corp annual Depreciation for 2023 was $20.5M, a 6.82% increase from 2022.
  • Adaptive Biotechnologies Corp annual Depreciation for 2022 was $19.2M, a 56.9% increase from 2021.
  • Adaptive Biotechnologies Corp annual Depreciation for 2021 was $12.3M, a 81% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.79M -$213K -4.26% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $5M +$367K +7.92% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $4.64M +$2.39M +106% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 $2.25M +$698K +44.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $1.55M +$190K +13.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $1.36M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.